Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | OTHER_GOV |
The aim of the study is to test if patients under oral anticoagulation therapy who are going to participate in the education program will have better Health-related quality of life, higher rate in pharmacological treatment adherence and better self efficacy to manage the treatment.
Patients who are going to use oral anticoagulant will participate in an individual orientation, using instructional material (slides and illustrative booklet) during hospitalization period. After the discharge 2 phone calls will be done (after: a week and four weeks) focusing on the strategies to improve patient's self-efficacy to manage the oral anticoagulation. There will be a personal contact among researcher and participants when the patients return at the oral anticoagulant ambulatory, two months after the treatment start. At this time the following variables of interest will be evaluated: Health-related quality of life; adherence to treatment and patients' self-efficacy.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Educational Program | Experimental | Patients who are going to use of oral anticoagulant will participate in an individual orientation, using instructional material (slides and illustrative booklet) during hospitalization period and the telephone follow-up at a week and four weeks after discharge |
|
| usual care | Other | Patients who are going to use of oral anticoagulant will have usual orientation from the health service (illustrative booklet) during hospitalization time. No telephone follow-up after discharge. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Educational program | Behavioral | Individual orientation (slides) during hospitalization period and telephone follow-up after discharge |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in health-related quality of life at 2 months | the health-related quality of life will be measure by Duke Anticoagulation Satisfaction Scale | baseline (hospitalization time) and two months after discahrge |
| Measure | Description | Time Frame |
|---|---|---|
| change from baseline in oral anticoagulation treatment adherence at 2 months | Treatment adhrence will be measure by on specif scale | baseline (hospitalization time) and two months after discahrge |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Flávia M Pelegrino, MNS, PhD candidate | Contact | 55-16-36023402 | flavia-martinelli@bol.com.br | |
| Inaiara A Scalçone, MNS, PhD candidate | Contact | 55-16-36023402 | inaenf@yahoo.com.br |
| Name | Affiliation | Role |
|---|---|---|
| Flávia M Pelegrino, MNS, PhD candidate | University of São Paulo at Ribeirão Preto College of Nursing | Principal Investigator |
| Inaiara S.A. Corbi, MNS, PhD candidate | University of São Paulo at Ribeirão Preto College of Nursing |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Estadual de Ribeirão Preto | Recruiting | Ribeirão Preto | São Paulo | 14090140 | Brazil |
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D020246 | Venous Thrombosis |
| D001281 | Atrial Fibrillation |
| D025861 | Blood Coagulation Disorders, Inherited |
| D006266 | Health Education |
| ID | Term |
|---|---|
| D013927 | Thrombosis |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D001145 | Arrhythmias, Cardiac |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Rosana A.S. Dantas, PhD | University of São Paulo at Ribeirão Preto College of Nursing | Study Director |
| D006331 |
| Heart Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001778 | Blood Coagulation Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D000099060 | Adherence Interventions |
| D055118 | Medication Adherence |
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |